Evidence map›Paper›PMID 28776440›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2017

Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors.

Belma Zengin Kurt, Fatih Sonmez, Serdar Durdagi, Busecan Aksoydan, Ramin Ekhteiari Salmas, Andrea Angeli, Mustafa Kucukislamoglu, Claudiu T Supuran

Abstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. A class of carbonic anhydrase IX/XII - selective carboxylate inhibitors.Journal of enzyme inhibition and medicinal chemistry · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Belma Zengin Kurta Faculty of Pharmacy, Department of Pharmaceutical Chemistry , Bezmialem Vakıf University , Istanbul , Turkey.
Fatih Sonmezb Faculty of Arts and Science, Department of Chemistry , Sakarya University , Sakarya , Turkey.
Serdar Durdagic Computational Biology and Molecular Simulations Laboratory, Department of Biophysics , School of Medicine, Bahcesehir University , Istanbul , Turkey.
Busecan Aksoydanc Computational Biology and Molecular Simulations Laboratory, Department of Biophysics , School of Medicine, Bahcesehir University , Istanbul , Turkey.
Ramin Ekhteiari Salmasc Computational Biology and Molecular Simulations Laboratory, Department of Biophysics , School of Medicine, Bahcesehir University , Istanbul , Turkey.
Andrea Angelid Dipartimento Neurofarba, Sezione di ScienzeFarmaceutiche e Nutraceutiche , Università degli Studi di Firenze , Florence , Italy.
Mustafa Kucukislamoglub Faculty of Arts and Science, Department of Chemistry , Sakarya University , Sakarya , Turkey.
Claudiu T Supurand Dipartimento Neurofarba, Sezione di ScienzeFarmaceutiche e Nutraceutiche , Università degli Studi di Firenze , Florence , Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New coumaryl-carboxamide derivatives with the thiourea moiety as a linker between the alkyl chains and/or the heterocycle nucleus were synthesized and their inhibitory activity against the human carbonic anhydrase (hCA) isoforms hCA I, II, VII and IX were evaluated. While the hCA I, II and VII isoforms were not inhibited by the investigated compounds, the tumour-associated isoform hCA IX was inhibited in the high nanomolar range. 2-Oxo-N-((2-(pyrrolidin-1-yl)ethyl)carbamothioyl)-2H-chromene-3-carboxamide (e11) exhibited a selective inhibitory action against hCA IX with the K

Indexed as

AlgorithmsCarbonic Anhydrase InhibitorsCarbonic Anhydrase IXCoumaric AcidsDose-Response Relationship, DrugHumansModels, MolecularMolecular StructureStructure-Activity RelationshipThioureaCarbonic Anhydrase InhibitorsCarbonic Anhydrase IXCoumaric AcidsThioureacarbonic anhydrasecarboxamidCoumarininduced fit dockingmolecular dockingquantum polarised ligand dockingthiourea

Identifiers

PMID28776440
PMCPMC6009903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.